On ECHEMI
Home > Drugs > Trapidil Tablets

Trapidil Tablets

Function and Efficacy

This product can inhibit the activity of cAMP phosphodiesterase, and has a stronger effect on dilating coronary arteries than nitroglycerin, which is beneficial to the establishment of collateral circulation; it can inhibit the synthesis of thromboxane A (TXA2), promote the production of prostacyclin (PGI2), dilate peripheral arteries and veins to inhibit platelet aggregation, prevent platelet aggregation induced by arachidonic acid and platelets themselves, and disaggregate the already formed aggregations; this product can also competitively antagonize platelet-derived growth factor (PDGF) receptors and inhibit the growth of smooth muscle cells.

Ingredients

Active ingredient: Trapidil.

Name Description Content CAS NO. Manufacturer
7-(DIETHYLAMINO)-5-METHYL-S-TRIAZOLO[1,5-A]PYRIMIDINEIngredients

It can inhibit the activity of cAMP phosphodiesterase, and has a stronger effect on dilating coronary arteries than nitroglycerin, which is beneficial to the establishment of collateral circulation; it can inhibit the synthesis of thromboxane A (TXA2), promote the production of prostacyclin (PGI2), dilate peripheral arteries and veins, inhibit platelet aggregation, prevent platelet aggregation induced by arachidonic acid and platelets themselves, and disaggregate the formed aggregations; it can also competitively antagonize platelet-derived growth factor (PDGF) receptors, inhibiting the growth of smooth muscle cells.

More
15421-84-8 3

Appearance

This product is white or off-white tablets.

Indication

Used to treat and prevent coronary heart disease, angina pectoris, myocardial infarction, etc.

Usage and Dosage

Oral administration: 50-100 mg (1-2 tablets) at a time, 3 times a day, or as directed by a doctor.

Adverse Reactions

It may cause adverse reactions such as decreased blood pressure.

Precautions

1. It is contraindicated for patients with unresolved intracranial hemorrhage. 2. It is contraindicated for patients who are allergic to this product. 3. It is contraindicated for pregnant and lactating women.

Special Population Medication

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

Drug Interactions

Not yet clear.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

50mg

Validity Period

Tentative 24 months

Manufacturer

Wuhan Di'ao Pharmaceutical Co., Ltd.

  • Founded in:

    1998-05-06
  • Address:

    Chenxi Road, Hannan Farm, Hannan District, Wuhan
  • Tax NO.:

    914201137071235068
  • Registered Funds:

    20 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.